Pharmaceutical

FORE Biotherapeutics raises funding to expedite plixorafenib development

FORE Biotherapeutics has raised $75m in its Series D investment round led by SR One to expedite the clinical development of plixorafenib.

Aug 24, 2023 - 20:00
FORE Biotherapeutics raises funding to expedite plixorafenib development
FORE Biotherapeutics has raised $75m in its Series D investment round led by SR One to expedite the clinical development of plixorafenib.
Read the original article

Tags:

Previous Article

XNK partners with Swedish hospital to develop AML therapy

Next Article

Japan grants patent for BioArctic’s Parkinson’s disease antibody

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pharmaceutical drug delivery market and systems

Pharmaceutical drug delivery market and systems

Mar 24, 2024

STAT+: First medicine developed to treat MASH expected to be approved soon

STAT+: First medicine developed to treat MASH expected ...

Mar 13, 2024

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech and CEPI partner to develop Mpox vaccine

Sep 19, 2023